amiodarone has been researched along with nitrofurantoin in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.67) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 12 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bryant, DH | 1 |
Martin, WJ | 2 |
Ward, MJ; White, JP | 1 |
Pannier, R | 1 |
Galeotta, G; Mammarella, A; Musca, A; Paoletti, V | 1 |
Mattila, MJ | 1 |
Carrión Valero, F; Marín Pardo, J | 1 |
Epler, GR | 1 |
Bischoff, A | 1 |
Freise, J; Wehmeier, P; Welte, T | 1 |
Camus, P; Roden, AC | 1 |
9 review(s) available for amiodarone and nitrofurantoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced pulmonary disease.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aerosols; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Aspirin; Bronchial Spasm; Contrast Media; Cough; Drug-Related Side Effects and Adverse Reactions; Humans; Lung Diseases; Nitrofurantoin | 1992 |
Pulmonary toxicity induced by chemical agents.
Topics: Amiodarone; Animals; Asbestos; Bleomycin; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Gold; Humans; Lung Diseases; Nitrofurantoin; Oxygen; Paraquat | 1990 |
Drug-induced adverse pulmonary reactions.
Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Hydrochlorothiazide; Hypertension, Pulmonary; Lung Diseases; Lupus Erythematosus, Systemic; Lymphatic Diseases; Mediastinum; Methotrexate; Nitrofurantoin; Penicillamine; Pleural Effusion; Pulmonary Edema; Pulmonary Eosinophilia; Pulmonary Fibrosis; Ritodrine | 1985 |
[Drug-induced lung diseases].
Topics: Adult; Aged; Amiodarone; Animals; Anticonvulsants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lung Diseases; Male; Nitrofurantoin | 1994 |
[Drug induced pulmonary symptoms in medicine].
Topics: Amiodarone; Amphotericin B; Bronchoconstriction; Drug-Related Side Effects and Adverse Reactions; Female; Finland; Humans; Incidence; Lung Diseases; Male; Nitrofurantoin; Penicillamine; Pneumonia; Pulmonary Edema; Risk Assessment; Salicylic Acid | 1996 |
[Pulmonary toxicity caused by drugs].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Bleomycin; Drug-Related Side Effects and Adverse Reactions; Humans; Lung; Lung Diseases; Nitrofurantoin; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Pulmonary Fibrosis; Radiography, Thoracic; Respiratory Insufficiency; Vasodilator Agents | 1999 |
Drug-induced bronchiolitis obliterans organizing pneumonia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Antineoplastic Agents; Cryptogenic Organizing Pneumonia; Humans; Iatrogenic Disease; Nitrofurantoin | 2004 |
Iatrogenic pulmonary lesions.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Early Medical Intervention; Equipment and Supplies; Humans; Hydrophobic and Hydrophilic Interactions; Iatrogenic Disease; Immunologic Factors; Lung; Lung Diseases, Interstitial; Nitrofurantoin; Polymers; Radiotherapy | 2018 |
21 other study(ies) available for amiodarone and nitrofurantoin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Pharmacologic and other chemical causes of interstitial lung disease.
Topics: Amiodarone; Bleomycin; Humans; Nitrofurantoin; Pulmonary Fibrosis | 1991 |
Drug induced lung disease.
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Antineoplastic Agents; Asthma; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Lung Diseases; Lupus Erythematosus, Systemic; Nitrofurantoin; Pulmonary Eosinophilia; Pulmonary Fibrosis; Sulfasalazine | 1983 |
Drug-induced interstitial pneumonia.
Topics: Amiodarone; Cytotoxins; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazolidines; Lung; Lung Diseases, Interstitial; Methotrexate; Nitrofurantoin; Paraffin; Protein-Tyrosine Kinases; Pulmonary Fibrosis | 2008 |
[Toxic effects on the lung: is "pneumonia" caused by drugs?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Antibiotics, Antineoplastic; Antirheumatic Agents; Bleomycin; Drug-Related Side Effects and Adverse Reactions; Humans; Lung; Lung Diseases; Methotrexate; Nitrofurantoin; Radiography, Thoracic; Risk Factors; Time Factors; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2009 |
[Drug-induced pulmonary interstitial disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Biopsy; Bronchoscopy; Comorbidity; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Nitrofurantoin; Pulmonary Alveoli; Tomography, X-Ray Computed | 2010 |